News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,299 Results
Type
Article (2475)
Company Profile (39)
Press Release (35785)
Section
Business (14389)
Career Advice (81)
Deals (2135)
Drug Delivery (7)
Drug Development (4240)
Employer Resources (10)
FDA (485)
Job Trends (801)
News (20706)
Policy (1127)
Tag
Academia (157)
Africa (45)
Alliances (3517)
Alzheimer's disease (41)
Antibody-drug conjugate (ADC) (6)
Approvals (482)
Arizona (12)
Artificial intelligence (4)
Asia (1883)
Australia (311)
Bankruptcy (11)
Best Places to Work (492)
Biosimilars (9)
Biotechnology (31)
C2C Services and Suppliers (2110)
California (262)
Canada (52)
Cancer (25)
Career advice (69)
Cell therapy (8)
China (11)
Clinical research (3145)
Collaboration (18)
Colorado (5)
Compensation (9)
Connecticut (7)
COVID-19 (182)
CRISPR (4)
Data (9)
Diabetes (5)
Diagnostics (477)
Drug discovery (4)
Earnings (4146)
Employer resources (8)
Europe (3950)
Events (5940)
Executive appointments (13)
FDA (490)
Florida (13)
Funding (15)
Gene editing (7)
Gene therapy (6)
GLP-1 (44)
Government (158)
Healthcare (737)
Hotbed/Location (28356)
Illinois (11)
Indiana (13)
Infectious disease (182)
Inflammatory bowel disease (10)
Inflation Reduction Act (5)
Interviews (8)
IPO (986)
IRA (5)
Job creations (307)
Job search strategy (65)
Kansas (12)
Layoffs (31)
Legal (227)
Liver cancer (5)
Lung cancer (7)
Maryland (11)
Massachusetts (82)
Medical device (315)
Medtech (315)
Mergers & acquisitions (1152)
Metabolic disorders (9)
Minnesota (7)
Neuroscience (51)
New Jersey (16)
New York (18)
NextGen Class of 2024 (358)
Non-profit (178)
North Carolina (57)
Northern California (117)
Ohio (16)
Opinion (14)
Patents (8)
Pennsylvania (14)
People (5562)
Phase I (1301)
Phase II (1553)
Phase III (899)
Pipeline (6)
Policy (7)
Postmarket research (43)
Preclinical (580)
Real estate (437)
Recruiting (5)
Regulatory (800)
Reports (5)
Research institute (154)
Resumes & cover letters (9)
South America (42)
Southern California (123)
Startups (490)
Texas (9)
United States (586)
Vaccines (20)
Washington State (10)
Date
Today (10)
Last 7 days (48)
Last 30 days (163)
Last 365 days (2864)
2024 (1945)
2023 (2940)
2022 (3847)
2021 (4141)
2020 (3607)
2019 (2246)
2018 (1694)
2017 (1909)
2016 (1709)
2015 (1949)
2014 (1434)
2013 (1229)
2012 (1458)
2011 (1382)
2010 (1227)
38,299 Results for "empirical bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cell BioEngines Secures an Additional $2 Million in Funding From SOSV and the Empire State Development’s New York Ventures
July 22, 2024
·
1 min read
Layoffs
Aadi Bioscience to Lay Off 80% of R&D Staff
Aadi Bioscience expects that pipeline adjustments and the workforce reduction will extend its cash runway into at least the second half of 2026.
August 21, 2024
·
1 min read
·
Angela Gabriel
Policy
Yield10 Bioscience Announces Delisting from Nasdaq
Yield10 Bioscience, Inc., an agricultural bioscience company, announced that Company has received a final delisting notice from Nasdaq.
May 15, 2024
·
3 min read
Press Releases
Precision BioSciences Announces its Addition to the Russell Microcap® Index
Precision BioSciences, Inc. today announced its addition to the Russell Microcap® Index.
July 1, 2024
·
9 min read
Drug Development
Genflow Biosciences PLC Announces Strengthening of Pre-Clinical Efforts
Genflow Biosciences Strengthens Pre-Clinical Efforts with FDA Guidance and CDMO and CRO Selection
June 27, 2024
·
6 min read
Marvel Biosciences Announces Private Placement Update
Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), wishes to announce that
June 21, 2024
·
2 min read
Solid Biosciences Joins the Russell 3000® Index
Solid Biosciences Inc. announced that the Company has been added to the broad-market Russell 3000® Index as part of the annual reconstitution, effective at the open of US equity markets, Monday, July 1st 2024.
July 1, 2024
·
5 min read
Biotech Beach
Neurocrine Biosciences to Participate at Investor Conferences in June 2024
Neurocrine Biosciences, Inc. will participate at two upcoming investor conferences in June.
May 29, 2024
·
2 min read
Partillion Bioscience’s Nanovial Products Available in Japan Through Distribution by Sony
Partillion Bioscience Corporation, a life science tools company, announced the commercial availability of its portfolio of single-cell analysis products in Japan.
July 1, 2024
·
3 min read
Genflow Biosciences Plc Announces Result of AGM
Genflow Biosciences Plc an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to announce that all resolutions proposed at the Annual General Meeting held earlier were duly passed.
June 27, 2024
·
1 min read
1 of 3,830
Next
